FutureFuel (FF) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
11 Aug, 2026Executive summary
Achieved total revenue of $78.7 million in Q2 2026, up 121% year-over-year, driven by strong growth in both Chemicals and Biofuels segments.
Returned to profitability with GAAP net income of $11.4 million, compared to a net loss of $14.2 million in Q2 2025, supported by improved production economics and cost discipline.
Adjusted EBITDA reached $11.8 million, a $23.2 million improvement year-over-year.
Regulatory clarity, including Clean Fuel Production Credit and EPA mandates, contributed to significant biofuels growth.
Resumed quarterly investor calls after more than a decade, signaling a commitment to transparency and consistent engagement.
Financial highlights
Q2 2026 revenue: $78.7 million (up 121% YoY); gross profit was $15.0 million, reversing a $12.4 million loss in Q2 2025.
Net income reached $11.4 million, compared to a net loss of $14.2 million a year ago; adjusted EBITDA was $11.8 million, versus a loss of $11.4 million in Q2 2025.
Net income per diluted share was $0.25, compared to a loss of $0.32 per share.
Cash flow from operations was $18.8 million, up from $5.2 million in Q2 2025.
Capital expenditures were $8.0 million in Q2, with $1.9 million customer-funded.
Outlook and guidance
On track to deliver positive adjusted EBITDA for full-year 2026, with robust demand expected in both segments.
Biofuels segment plant utilization expected to increase in the second half of 2026.
Monetization of tax credits (CFPC and SPTC) is expected to provide additional cash flow at each fiscal year end.
Sufficient liquidity is anticipated to fund operations, capital requirements, and dividends.
Elevated input costs, especially for soybean oil, remain a near-term headwind but are expected to revert to mean levels, potentially improving margins.
Latest events from FutureFuel
- Annual meeting to elect directors, approve pay, and ratify auditor, with board size reduced.FF
Proxy filing - Revenue up 82% year-over-year, but net loss widened on derivative and storm impacts.FF
Q1 2026 - 2025 saw steep losses and revenue declines, but new plant investments and regulatory clarity support a 2026 rebound.FF
Q4 2025 - Annual meeting to elect directors, ratify auditor, and update governance and compensation.FF
Proxy Filing - Shareholders will elect directors, ratify a new auditor, and see board and leadership changes.FF
Proxy Filing - Q3 2025 revenue dropped 56% with a $9.3M net loss amid biofuel market and regulatory headwinds.FF
Q3 2025 - Q2 2025 revenue fell 51% and net loss reached $10.4M as biodiesel production was idled.FF
Q2 2025 - Q3 loss and cash decline driven by biofuel weakness, margin pressure, and special dividend.FF
Q3 2024 - Q2 net income reached $9.6M as margins improved despite lower revenue and market pressures.FF
Q2 2024